7517 POSTER Clinical tolerability of trabectedin administered by two different schedules (weekly for 3 of 4 weeks vs q3 weeks) in patients with advanced/metastatic liposarcoma or leiomyosarcoma (L-sarcomas) progressing despite prior treatment with at least anthracycline and ifosfamide
Year: 2007
Type: conference-abstract
Authors: S. Chawla, P.G. Casali, M. von Mehren, A. Le Cesne, J.Y. Blay, C. Lebedinsky, V. Alfaro, Y. Elsayed, B. Michiels, G.D. Demetri
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2069037359